1. Basic Information of the Announcement
Alchemy Investments Acquisition Corp 1 (Nasdaq: ALCYU, ALCY, ALCYW) (“Alchemy” or the “Company”) posted a Form 425 filing, as included in its Form 8-K, on May 8, 2026, indicating receipt of a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”). The Notice states that the Company’s securities are subject to delisting following the Company’s failure to meet the requirement under Nasdaq Interpretive Material IM-5101-2. This stipulation mandates that special purpose acquisition companies complete a business combination within 36 months of the effectiveness of their initial public offering (IPO) registration statement.
2. Transaction Overview
According to the filing, Alchemy, a special purpose acquisition company, was required to complete a business combination—intended as a merger or similar transaction—by May 4, 2026. As disclosed, the Company did not consummate an initial business combination within this timeframe. Consequently, Nasdaq has notified Alchemy that its securities are now subject to delisting. The Company has indicated that it will not appeal the decision, and trading of its securities on Nasdaq is scheduled to be suspended at the opening of business on May 14, 2026.
4. Key Transaction Terms
• Under Nasdaq IM-5101-2, Alchemy was obligated to complete one or more business combinations within 36 months after the effectiveness of its IPO registration statement, which occurred on May 4, 2023. • Since the Company did not meet this requirement by May 4, 2026, its securities are subject to removal from listing on the Nasdaq Stock Market. • Unless the determination is appealed and reversed, a Form 25-NSE will be filed with the Securities and Exchange Commission to effectuate the removal of Alchemy’s securities from Nasdaq. • The Company has disclosed that it will not submit a timely appeal, thus proceeding with the delisting schedule.
5. Company Statements and Forward-Looking Statements
In its submission, Alchemy stated it “will not appeal Nasdaq’s determination to delist the Company’s securities,” and as a result “the Company’s securities will be suspended from trading on Nasdaq at the opening of business on May 14, 2026.” However, Alchemy also disclosed it “expects its securities will commence trading on the over-the-counter market on May 14, 2026.” These and other statements regarding future events constitute forward-looking statements that may involve known and unknown risks, uncertainties, and other factors that could cause actual results to differ from projections.
